Openbookopenbook
Equity
StockUS listing USMRMNASDAQConsumer CyclicalStructurally Challenged

Medirom Healthcare Technologies Inc(MRM) Stock Analysis | Consumer Cyclical

USD --+0.00%
Reward29Low
Risk64Medium-High
75%Data
Thin 1% profit margin · Revenue down 7% YoY
USD —+0.00 (+0.00%) Previous close · NASDAQ
Market cap 5.85M
Reward Ratingⓘ29 Low reward assessment · 75% data coverage
Bottom 1% of stocksView factors
Risk Ratingⓘ64 Medium-High risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on MRM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Medirom Healthcare Technologies Inc?

, together with its subsidiaries, provides holistic health services in Japan.

AI Brief Pro

The brief on Medirom Healthcare Technologies Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Medirom Healthcare Technologies Inc?

, together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The company is listed on the NASDAQ in USA, operating in the Consumer Cyclical sector, with a market capitalisation of 5.85M, and a P/E ratio of 1.9x.

Financial Highlights

Investment Breakdown

Growth
Revenue growth is subdued, limiting near-term earnings expansion.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Low (29)

Similar stocks to compare

A short list of Personal Services names that are close enough in size to make side-by-side comparison useful.

ICDXNano Cap / 8.4M market cap
ICDX
Compare
EVTKNano Cap / 8.4M market cap
Eventiko Inc
Compare
IVPNano Cap / 4M market cap
Inspire Veterinary Partners, Inc. Class A Common Stock
Compare
Company Information
SectorConsumer Cyclical
IndustryPersonal Services
Market Cap5.85M
P/E Ratio1.9476
Dividend YieldN/A
Beta1.058
Insider Activity
12M windowNo data
No insider activity data available for this ticker.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.